{"product_id":"american-society-of-nephrology-kidney-week-genetics-in-clinical-nephrology-2025","title":"American Society of Nephrology Kidney Week Genetics in Clinical Nephrology 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: nephrologists, physician‑scientists, geneticists\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe Genetics in Clinical Nephrology course was a dedicated Early Program held on the Wednesday immediately preceding the main ASN Kidney Week 2025 Annual Meeting.\u003c\/p\u003e\n\u003cp\u003eThis comprehensive full-day session was designed to demystify the rapidly expanding role of genetics in daily nephrology practice. It moved beyond the “research” phase to focus on the practical clinical integration of genetic testing, helping clinicians understand when to test, how to interpret complex results (like Variants of Uncertain Significance), and how these findings directly alter patient management and family counseling.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eWhat You Will Learn\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eThe curriculum focused on actionable “nephrogenetics.” Key learning outcomes included:\u003c\/h3\u003e\n\u003cp\u003eTesting Modalities: A clear guide on choosing the right test—knowing when to order a targeted Next-Generation Sequencing (NGS) panel versus Whole Exome Sequencing (WES) or Whole Genome Sequencing (WGS).\u003c\/p\u003e\n\u003cp\u003eTransplant Implications: How genetic findings change the risk assessment for living related donors (e.g., in APOL1-mediated disease or Alport syndrome) to prevent “donating” the disease.\u003c\/p\u003e\n\u003cp\u003eTherapeutic Targets: Updates on new precision therapies that target specific genetic pathways in Polycystic Kidney Disease (ADPKD) and complement-mediated Thrombotic Microangiopathy (TMA).\u003c\/p\u003e\n\u003cp\u003eVariant Interpretation: A workshop-style breakdown of the ACMG (American College of Medical Genetics) classification system to help clinicians understand the difference between “Pathogenic” and “Benign.”\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eEvent Details\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eEvent: Genetics in Clinical Nephrology (ASN Early Program)\u003c\/p\u003e\n\u003cp\u003eDate: November 5, 2025 (Wednesday)\u003c\/p\u003e\n\u003cp\u003eLocation: Room 310A, George R. Brown Convention Center, Houston, Texas, USA\u003c\/p\u003e\n\u003cp\u003eChairs: Arlene B. Chapman, MD \u0026amp; Emilie Cornec-Le Gall, MD, PhD.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eWho Should Attend\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eGeneral Nephrologists: Who are seeing an increasing number of patients with “unknown etiology” CKD (which is often genetic).\u003c\/p\u003e\n\u003cp\u003eTransplant Nephrologists: Who need to screen living donors and recipients for hereditary risks.\u003c\/p\u003e\n\u003cp\u003eGenetic Counselors: Working within renal clinics.\u003c\/p\u003e\n\u003cp\u003ePediatric Nephrologists: For whom genetics is a cornerstone of diagnosis (CAKUT, nephrotic syndromes).\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eWhy Attend (or Watch)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe “Black Box” Problem: The course specifically addresses the “fear” many clinicians have of genetic reports, providing tools to confidently explain results to patients without needing a PhD in genetics.\u003c\/p\u003e\n\u003cp\u003eRare Disease Registry: Insights from the RaDaR (Rare Diseases Registry) and the 100,000 Genomes Project, showing how big data is reclassifying diseases we thought we understood.\u003c\/p\u003e\n\u003cp\u003eInteractive Workshops: Unlike standard lectures, the afternoon sessions included small-group workshops on “Family History Taking” and “Ethical Considerations in Living Donation,” allowing for direct faculty mentorship.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eThe agenda featured specific high-yield modules:\u003c\/h3\u003e\n\u003ch3\u003eFoundations:\u003c\/h3\u003e\n\u003cp\u003eUpdates on Genetic Kidney Diseases (Gabriel Loeb, MD, PhD).\u003c\/p\u003e\n\u003cp\u003eUnderstanding Genetic Testing: NGS vs. WES vs. WGS (Peter C. Harris, PhD).\u003c\/p\u003e\n\u003ch3\u003eClinical Applications:\u003c\/h3\u003e\n\u003cp\u003eGenetic Testing in Kidney Transplantation (Ali G. Gharavi, MD).\u003c\/p\u003e\n\u003cp\u003eUnraveling the Genetics of Thrombotic Microangiopathy (Anuja Java, MD).\u003c\/p\u003e\n\u003ch3\u003eWorkshops:\u003c\/h3\u003e\n\u003cp\u003eFamily History \u0026amp; ACMG Classification (Matthew Lanktree, MD, PhD).\u003c\/p\u003e\n\u003cp\u003eEthical Considerations in Living Kidney Donation.\u003c\/p\u003e\n\u003ch3\u003eCase Studies:\u003c\/h3\u003e\n\u003cp\u003eNephrogenetic Clinical Cases: Real-world examples of how a genetic diagnosis changed the treatment plan (Arlene B. Chapman, MD).\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405800394948,"sku":null,"price":130.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/American-Society-of-Nephrology-Kidney-Week-Genetics-in-Clinical-Nephrology-2025.jpg?v=1784216353","url":"https:\/\/medicalcoursespro.com\/products\/american-society-of-nephrology-kidney-week-genetics-in-clinical-nephrology-2025","provider":"Medicalcoursespro","version":"1.0","type":"link"}